Marilys Corbex: On the Side of the People
BCG Plus Immunotherapy Shows Modest Recurrence Benefit but Higher Toxicity in BCG-Naïve High-Risk NMIBC
Wafik El-Deiry: Scientific Freedom and Diverse Thinking Drive Better Medicine
CLARITY-Gastric01: Sonesitatug Vedotin Improves Overall Survival in 2L+ CLDN18.2-Positive Advanced Gastric/GEJ Cancers
Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring
SABCS 2026 Male Breast Cancer Advocate Scholarship
Herbert Loong: Prospective Open-labelled Phase 2 Pembrolizumab in Acral Lentiginous Melanoma
RxPONDER Analysis: Ovarian Reserve May Refine Chemotherapy Decisions in HR-Positive Breast Cancer
The ALRCaN Global webinar, “FLT3-Mutated AML: Biology and Treatment,” is scheduled for Friday, July 31, 2026, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT). Presented by Mark J. Levis and organized by the Acute Leukemia Research and Care Network (ALRCaN), the webinar is part of the network’s weekly educational series […]
